SG167656A1 - Composition for the treatment of skin conditions - Google Patents

Composition for the treatment of skin conditions

Info

Publication number
SG167656A1
SG167656A1 SG200505097-6A SG2005050976A SG167656A1 SG 167656 A1 SG167656 A1 SG 167656A1 SG 2005050976 A SG2005050976 A SG 2005050976A SG 167656 A1 SG167656 A1 SG 167656A1
Authority
SG
Singapore
Prior art keywords
skin conditions
treatment
composition
acrochordon
removal
Prior art date
Application number
SG200505097-6A
Other languages
English (en)
Inventor
Mickey Miller
Margaret Ancira
Original Assignee
Mickey Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mickey Miller filed Critical Mickey Miller
Publication of SG167656A1 publication Critical patent/SG167656A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
SG200505097-6A 2001-02-09 2002-02-08 Composition for the treatment of skin conditions SG167656A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26797801P 2001-02-09 2001-02-09

Publications (1)

Publication Number Publication Date
SG167656A1 true SG167656A1 (en) 2011-01-28

Family

ID=23020931

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200505097-6A SG167656A1 (en) 2001-02-09 2002-02-08 Composition for the treatment of skin conditions

Country Status (13)

Country Link
US (1) US7138146B2 (fr)
EP (1) EP1365781B1 (fr)
JP (1) JP2004518715A (fr)
CN (1) CN100508990C (fr)
AT (1) ATE397452T1 (fr)
BR (1) BR0207163A (fr)
CA (1) CA2437823A1 (fr)
DE (1) DE60226953D1 (fr)
IL (1) IL157321A0 (fr)
MX (1) MXPA03007151A (fr)
NZ (1) NZ527673A (fr)
SG (1) SG167656A1 (fr)
WO (1) WO2002064151A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852832B1 (fr) 2003-03-25 2008-06-27 Oreal Composition de coloration pour fibres keratiniques comprenant un acide hydroxycarboxilique ou un sel, composition prete a l'emploi la comprenant, procede de mise en oeuvre et dispositif
US8257780B2 (en) 2003-10-31 2012-09-04 Resource Development L.L.C. Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
KR20060004399A (ko) * 2004-07-09 2006-01-12 에스케이케미칼주식회사 자기발열체를 이용한 케토프로펜의 경피투여 시스템
WO2006085302A2 (fr) * 2005-02-08 2006-08-17 Bmz Diagnosis (2004) Ltd. Composition pour traiter des troubles de peau
FR2947452B1 (fr) * 2009-07-01 2012-04-20 Fabre Pierre Dermo Cosmetique L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
JP5431501B2 (ja) * 2010-01-13 2014-03-05 株式会社東芝 画像処理装置、及びその方法
WO2012177799A1 (fr) * 2011-06-20 2012-12-27 Atheronova Operations, Inc. Réduction de la graisse sous-cutanée
EP3134061B1 (fr) * 2014-04-21 2020-10-07 Aclaris Therapeutics, Inc. Formules de peroxyde et procédés et applicateurs pour leur utilisation
JP6543091B2 (ja) * 2014-06-03 2019-07-10 御木本製薬株式会社 Ｐｍｅｌ１７遺伝子発現抑制剤
CN105557691B (zh) * 2015-12-31 2018-07-20 中国检验检疫科学研究院 一种枣实蝇引诱剂及其应用
CN108459157B (zh) * 2018-01-11 2020-11-27 中国药科大学 一种预测伊立替康化疗毒性生物标志物的组合物
CN110898076A (zh) * 2019-12-12 2020-03-24 刘贤贤 一种去除角质的药物及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826681A (en) * 1985-02-26 1989-05-02 L'oreal Anhydrous solution of hydrogen peroxide in an organic solvent and the use of the same in therapeutic and cosmetic formulations
JPH04159229A (ja) * 1990-09-14 1992-06-02 Senju Pharmaceut Co Ltd 真珠腫治療剤
EP0601891A1 (fr) * 1992-12-11 1994-06-15 Japan Lotion Company Agent antifongique et pour favoriser la cicatrisation de la peau
WO1999037295A1 (fr) * 1998-01-21 1999-07-29 Devillez Richard L Procede et composition de traitement de la peau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954974A (en) 1972-06-09 1976-05-04 Paul Herzog Disinfectant for the surface of human body parts containing hydrogen peroxide
US4018802A (en) 1975-04-09 1977-04-19 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
US4128564A (en) 1976-03-22 1978-12-05 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins
US4485091A (en) 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4438102A (en) 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth
US5380764A (en) * 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
GB9007762D0 (en) 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
GB2285218A (en) 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
US5594015A (en) 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
US5736582A (en) 1996-10-10 1998-04-07 Devillez; Richard L. Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US6028104A (en) 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US6146640A (en) 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826681A (en) * 1985-02-26 1989-05-02 L'oreal Anhydrous solution of hydrogen peroxide in an organic solvent and the use of the same in therapeutic and cosmetic formulations
JPH04159229A (ja) * 1990-09-14 1992-06-02 Senju Pharmaceut Co Ltd 真珠腫治療剤
EP0601891A1 (fr) * 1992-12-11 1994-06-15 Japan Lotion Company Agent antifongique et pour favoriser la cicatrisation de la peau
WO1999037295A1 (fr) * 1998-01-21 1999-07-29 Devillez Richard L Procede et composition de traitement de la peau

Also Published As

Publication number Publication date
WO2002064151A1 (fr) 2002-08-22
NZ527673A (en) 2005-03-24
EP1365781B1 (fr) 2008-06-04
DE60226953D1 (de) 2008-07-17
BR0207163A (pt) 2004-06-29
IL157321A0 (en) 2004-02-19
CN1501804A (zh) 2004-06-02
CA2437823A1 (fr) 2002-08-22
EP1365781A1 (fr) 2003-12-03
US7138146B2 (en) 2006-11-21
MXPA03007151A (es) 2004-10-15
CN100508990C (zh) 2009-07-08
US20030008018A1 (en) 2003-01-09
ATE397452T1 (de) 2008-06-15
EP1365781A4 (fr) 2005-01-12
JP2004518715A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
DE60107065D1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
SG167656A1 (en) Composition for the treatment of skin conditions
TW200509956A (en) Compositions and methods for treatment of rosacea
WO2002044187A3 (fr) Composes metalliques de type salene cycliques: piegeurs d'especes d'oxygene reactif utiles comme antioxydants dans le traitement et la prevention d'affections
IL156122A0 (en) Geldanamycin derivative and method of treating cancer using same
NO20041598L (no) Fremgangsmater for behandling eller profylakse av vaskulaer betennelse ved anvendelse av sterolabsorpsjonsinhibitor(er)
WO2003020202A3 (fr) Methode permettant de reduire l'hypertension et l'insuffisance cardiaque
WO2003024386A8 (fr) Utilisation d'inhibiteurs c-kit puissants, selectifs et non toxiques pour le traitement de la cystopathie interstitielle sous-muqueuse
WO2004093995A3 (fr) Utilisation d'antioxydants pour traiter les troubles associes a la perte osseuse
NO20051681L (no) Lysaldring av hud og aktinskadebehandling
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
WO2004017917A3 (fr) Procede pour la prevention et/ou le traitement de l'atherosclerose
WO2003049674A3 (fr) Methode de traitement de virus enveloppes faisant appel a des esters d'huile de jojoba
DE69911212D1 (de) Anwendung der hemoproteine in der therapie
CZ20011642A3 (cs) Léčivo pro prevenci progrese aterosklerózy u savců
WO2004098505A3 (fr) Attenuation des lesions ischemiques/de reperfusion
WO2000032155A3 (fr) Compositions pour soins de la peau renfermant des sels de zinc et des retinoides
UA36309A (uk) Спосіб лікування виразкової хвороби, ускладненої перфорацією або кровотечею, у людей похилого віку
BR0312402A (pt) Utilização de inibidores seletivos de ciclooxigenase-2 e agentes trombolìticos para o tratamento ou prevenção de um episódio vaso-oclusivo
Sever et al. Unusual contact burn due to argon gas
Kim et al. A Potent Antioxidant, KR 31378
UA37607A (uk) Спосіб лікування кровотечі з варикозно-розширених вен стравоходу
UA37531A (uk) Спосіб хірургічного лікування глибоких опіків
UA33359A (uk) Спосіб доступу до пухлин орбіти